No credit card. No commitment.
5000+ G2 reviews
Kedalion Therapeutics
Research
Founded in 2015
Menlo Park, California
kedalionthera.comKedalion Therapeutics
ResearchFounded in 2015Menlo Park, California
EmployeesKedalion Therapeutics' financial review
Kedalion Therapeutics' Revenue (Yearly)
4M
Employees
7
Total Funding
5M
Kedalion Therapeutics information
Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following s...
Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.
Kedalion Therapeutics industries
Research
Biotechnology research
Kedalion Therapeutics' financial review
Kedalion Therapeutics' Revenue (Yearly)
4M
Employees
7
Total Funding
5M
Employee Metrics
Technologies
Content Delivery Networks
Domain Name Services
Hosting
Other
Business Intelligence
Other
Notable Alumni
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
